203 related articles for article (PubMed ID: 18491171)
1. Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock.
Debrunner M; Schuiki E; Minder E; Straumann E; Naegeli B; Mury R; Bertel O; Frielingsdorf J
Clin Res Cardiol; 2008 May; 97(5):298-305. PubMed ID: 18491171
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory response to acute myocardial infarction complicated by cardiogenic shock.
Pudil R; Krejsek J; Pidrman V; Gregor J; Tichý M; Bures J
Acta Medica (Hradec Kralove); 2001; 44(4):149-51. PubMed ID: 11836852
[TBL] [Abstract][Full Text] [Related]
3. Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.
Prondzinsky R; Unverzagt S; Lemm H; Wegener N; Heinroth K; Buerke U; Fiedler M; Thiery J; Haerting J; Werdan K; Buerke M
Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):476-84. PubMed ID: 22810435
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction.
Patti G; Mega S; Pasceri V; Nusca A; Giorgi G; Zardi EM; D'Ambrosio A; Dobrina A; Di Sciascio G
Clin Cardiol; 2005 Apr; 28(4):193-6. PubMed ID: 15869054
[TBL] [Abstract][Full Text] [Related]
5. [Dynamics of interleukin 6 levels in the patients with cardiogenic and septic shock and in a control group of patients with uncomplicated AMI].
Pařenica J; Maláska J; Jarkovský J; Helánová K; Jabandžiev P; Michálek J; Veselková Z; Littnerová S; Kubková L; Gál R; Sevčík P; Goldbergová MP; Litzman J; Čermáková Z; Špinar J
Vnitr Lek; 2014 Feb; 60(2):114-22. PubMed ID: 24754415
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock.
Prondzinsky R; Unverzagt S; Lemm H; Wegener NA; Schlitt A; Heinroth KM; Dietz S; Buerke U; Kellner P; Loppnow H; Fiedler MG; Thiery J; Werdan K; Buerke M
Clin Res Cardiol; 2012 May; 101(5):375-84. PubMed ID: 22212516
[TBL] [Abstract][Full Text] [Related]
7. Circulating microparticles are associated with clinical severity of persistent ST-segment elevation myocardial infarction complicated with cardiogenic shock.
Sionis A; Suades R; Sans-Roselló J; Sánchez-Martínez M; Crespo J; Padró T; Cubedo J; Ferrero-Gregori A; Vila-Perales M; Duran-Cambra A; Badimon L
Int J Cardiol; 2018 May; 258():249-256. PubMed ID: 29544939
[TBL] [Abstract][Full Text] [Related]
8. Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock.
Gjesdal G; Braun OÖ; Smith JG; Scherstén F; Tydén P
BMC Cardiovasc Disord; 2018 Jan; 18(1):8. PubMed ID: 29347907
[TBL] [Abstract][Full Text] [Related]
9. [Changes of Nonspecific Proteinases and Proinflammatory Cytokines in the Clinical Course of Acute Myocardial Infarction of Various Severity].
Soldatova OV; Kubyshkin AV; Gordienko AI; Fomochkina II
Kardiologiia; 2018 Mar; (3):5-12. PubMed ID: 29782265
[TBL] [Abstract][Full Text] [Related]
10. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia.
de Werra I; Jaccard C; Corradin SB; Chioléro R; Yersin B; Gallati H; Assicot M; Bohuon C; Baumgartner JD; Glauser MP; Heumann D
Crit Care Med; 1997 Apr; 25(4):607-13. PubMed ID: 9142024
[TBL] [Abstract][Full Text] [Related]
11. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
[TBL] [Abstract][Full Text] [Related]
12. Cardiogenic shock: the role of inflammation.
Shpektor A
Acute Card Care; 2010 Dec; 12(4):115-8. PubMed ID: 21039083
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial.
Fuernau G; Poenisch C; Eitel I; Denks D; de Waha S; Pöss J; Heine GH; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
Int J Cardiol; 2015 Jul; 191():159-66. PubMed ID: 25965624
[TBL] [Abstract][Full Text] [Related]
14. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
[TBL] [Abstract][Full Text] [Related]
15. Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes.
Mizia-Stec K; Gasior Z; Zahorska-Markiewicz B; Janowska J; Szulc A; Jastrzebska-Maj E; Kobielusz-Gembala I
Coron Artery Dis; 2003 Sep; 14(6):431-8. PubMed ID: 12966263
[TBL] [Abstract][Full Text] [Related]
16. Plasma cytokine levels predict mortality in patients with acute renal failure.
Simmons EM; Himmelfarb J; Sezer MT; Chertow GM; Mehta RL; Paganini EP; Soroko S; Freedman S; Becker K; Spratt D; Shyr Y; Ikizler TA;
Kidney Int; 2004 Apr; 65(4):1357-65. PubMed ID: 15086475
[TBL] [Abstract][Full Text] [Related]
17. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock?
Slater J; Brown RJ; Antonelli TA; Menon V; Boland J; Col J; Dzavik V; Greenberg M; Menegus M; Connery C; Hochman JS
J Am Coll Cardiol; 2000 Sep; 36(3 Suppl A):1117-22. PubMed ID: 10985714
[TBL] [Abstract][Full Text] [Related]
18. Peroxiredoxin 1 induces inflammatory cytokine response and predicts outcome of cardiogenic shock patients necessitating extracorporeal membrane oxygenation: an observational cohort study and translational approach.
Liu CH; Kuo SW; Hsu LM; Huang SC; Wang CH; Tsai PR; Chen YS; Jou TS; Ko WJ
J Transl Med; 2016 May; 14(1):114. PubMed ID: 27142532
[TBL] [Abstract][Full Text] [Related]
19. Infectious Complications and Immune/Inflammatory Response in Cardiogenic Shock Patients: A Prospective Observational Study.
Parenica J; Jarkovsky J; Malaska J; Mebazaa A; Gottwaldova J; Helanova K; Litzman J; Dastych M; Tomandl J; Spinar J; Dostalova L; Lokaj P; Tomandlova M; Pavkova MG; Sevcik P; Legrand M;
Shock; 2017 Feb; 47(2):165-174. PubMed ID: 27749762
[TBL] [Abstract][Full Text] [Related]
20. Emergent angioplasty prevents left ventricular dilation in patients with acute anterior wall myocardial infarction and cardiogenic shock.
Iwamori K; Sakata K; Kurihara H; Yoshino H; Ishikawa K
Clin Cardiol; 2000 Oct; 23(10):743-50. PubMed ID: 11061052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
